Found: 12
Select item for more details and to access through your institution.
Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Themis is indispensable for IL-2 and IL-15 signaling in T cells.
- Published in:
- Science Signaling, 2022, v. 15, n. 721, p. 1, doi. 10.1126/scisignal.abi9983
- By:
- Publication type:
- Article
Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response.
- Published in:
- Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01318-3
- By:
- Publication type:
- Article
Epigenome-augmented eQTL-hotspots reveal genome-wide transcriptional programs in 36 human tissues.
- Published in:
- Briefings in Bioinformatics, 2024, v. 25, n. 3, p. 1, doi. 10.1093/bib/bbae109
- By:
- Publication type:
- Article
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1–2 follicular lymphoma: a real-world multicenter study.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00462-z
- By:
- Publication type:
- Article
The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 9, p. 5267, doi. 10.3390/ijerph19095267
- By:
- Publication type:
- Article
Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0723-0
- By:
- Publication type:
- Article
Blood urea nitrogen to serum albumin ratio as a new prognostic indicator in critical patients with chronic heart failure.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 2, p. 1360, doi. 10.1002/ehf2.13825
- By:
- Publication type:
- Article
MiR‐3130‐5p is an intermediate modulator of 2q33 and influences the invasiveness of lung adenocarcinoma by targeting NDUFS1.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 11, p. 3700, doi. 10.1002/cam4.3885
- By:
- Publication type:
- Article
Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 4, p. 439, doi. 10.1007/s40268-023-00442-6
- By:
- Publication type:
- Article
Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.780118
- By:
- Publication type:
- Article
Therapeutic Interaction of Apatinib and Chidamide in T-cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic Apoptosis.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 10, p. 977, doi. 10.3390/jpm11100977
- By:
- Publication type:
- Article